New inhibitor drug shows promise in preventing diabetic eye and kidney disease

To ad­dress the con­tin­ued short­age of Pfiz­er’s syphilis drug amid ris­ing cas­es in the US, the FDA has ap­proved the tem­po­rary im­port of ex­ten­cilline from

The revenue for Ustekinumab Biosimilar is expected to reach an annual total of $285 mn by 2028 globally based off GlobalData’s Revenue Model. The drug’s